摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl (3R,4R,5R)-3,4-(acetylepimino)-5-(1-ethyl-propoxy)-cyclohex-1-ene-1-carboxylate | 1234466-30-8

中文名称
——
中文别名
——
英文名称
methyl (3R,4R,5R)-3,4-(acetylepimino)-5-(1-ethyl-propoxy)-cyclohex-1-ene-1-carboxylate
英文别名
methyl (1R,5R,6R)-7-acetyl-5-pentan-3-yloxy-7-azabicyclo[4.1.0]hept-2-ene-3-carboxylate
methyl (3R,4R,5R)-3,4-(acetylepimino)-5-(1-ethyl-propoxy)-cyclohex-1-ene-1-carboxylate化学式
CAS
1234466-30-8
化学式
C15H23NO4
mdl
——
分子量
281.352
InChiKey
NKJIUBCETDHTRO-QFBZGTDSSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    20
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.73
  • 拓扑面积:
    55.6
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl (3R,4R,5R)-3,4-(acetylepimino)-5-(1-ethyl-propoxy)-cyclohex-1-ene-1-carboxylate 在 sodium azide 、 氯化铵 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 16.0h, 以68%的产率得到methyl (3S,4R,5R)-4-acetamido-3-azido-5-(1-ethylpropoxy)-cyclohex-1-ene-1-carboxylate
    参考文献:
    名称:
    Carbocycles Related to Oseltamivir as Influenza Virus Group-1-Specific Neuraminidase Inhibitors. Binding to N1 Enzymes in the Context of Virus-like Particles
    摘要:
    We report here the exploitation of the 150-cavity in the active sites of group-1 neuraminidases for the design of new triazole-containing carbocycles related to oseltamivir. Inhibition studies with virus-like particles (VLPs) containing the influenza virus neuraminidase-1 (NI) activity indicate that several candidates are inhibitors, with K(i) values in the 10(-5)-10(-8) M range. In contrast, a known candidate that preserves the free amino group and a new candidate containing a guanidine function are better inhibitors, with K(i) values of 1.5 x 10(-9) and 4.6 x 10(-10) M, respectively. The most active inhibitor of the N1 enzyme in the triazole series was selective for the N1 class and showed significantly less inhibition (K(i) = 2.6 mu M vs 0.07 mu M) of the free influenza virus neuraminidase-2 (N2). In addition, saturation transfer difference (STD) NMR spectroscopic studies with this compound and the VLPs show that the entire molecule forms contacts with residues in the active site. These data taken together support our proposed binding mode in which the active site and the adjoining 150-cavity are both occupied.
    DOI:
    10.1021/jm100822f
  • 作为产物:
    描述:
    methyl (1R,5R,6R)-5-pentan-3-yloxy-7-azabicyclo[4.1.0]hept-2-ene-3-carboxylate乙酰氯三乙胺 作用下, 以 二氯甲烷 为溶剂, 以75%的产率得到methyl (3R,4R,5R)-3,4-(acetylepimino)-5-(1-ethyl-propoxy)-cyclohex-1-ene-1-carboxylate
    参考文献:
    名称:
    [EN] COMPOUNDS AND METHODS FOR TREATMENT OF INFLUENZA
    [FR] COMPOSÉS ET MÉTHODES POUR LE TRAITEMENT DU VIRUS INFLUENZA
    摘要:
    本发明部分提供了一种化合物,其化学式为(I)或其药用盐或立体异构体:其中R1选自以下组:取代三唑基团、胍基团、脲基团、硫脲基团、酰胺基团和N3;R2选自以下组:H、Me、Et和氨基酸,以及其方法和用途。
    公开号:
    WO2010075636A1
点击查看最新优质反应信息

文献信息

  • [EN] COMPOUNDS AND METHODS FOR TREATMENT OF INFLUENZA<br/>[FR] COMPOSÉS ET MÉTHODES POUR LE TRAITEMENT DU VIRUS INFLUENZA
    申请人:UNIV FRASER SIMON
    公开号:WO2010075636A1
    公开(公告)日:2010-07-08
    The present invention provides in part a compound of Formula (I) or a pharmaceutically- acceptable salt or stereoisomer thereof: where R1 is selected from the group consisting of a substituted triazole group, a guanidine group, a urea group, a thiourea group, an amidine group, and N3; and R2 is selected from the group consisting of H, Me, Et and an amino acid, and methods and uses thereof.
    本发明部分提供了一种化合物,其化学式为(I)或其药用盐或立体异构体:其中R1选自以下组:取代三唑基团、胍基团、脲基团、硫脲基团、酰胺基团和N3;R2选自以下组:H、Me、Et和氨基酸,以及其方法和用途。
  • Serendipitous Discovery of a Potent Influenza Virus A Neuraminidase Inhibitor
    作者:Sankar Mohan、Philip S. Kerry、Nicole Bance、Masahiro Niikura、B. Mario Pinto
    DOI:10.1002/anie.201308142
    日期:2014.1.20
    We have previously reported a potent neuraminidase inhibitor that comprises a carbocyclic analogue of zanamivir in which the hydrophilic glycerol side chain is replaced by the hydrophobic 3‐pentyloxy group of oseltamivir. This hybrid inhibitor showed excellent inhibitory properties in the neuraminidase inhibition assay (Ki=0.46 nM; Ki (zanamivir)=0.16 nM) and in the viral replication inhibition assay
    我们以前曾报道过一种有效的神经氨酸酶抑制剂,该抑制剂包含扎那米韦的碳环类似物,其中亲水性甘油侧链被奥司他韦的疏水3-戊氧基取代。这种杂合抑制剂在神经氨酸酶抑制试验(K i = 0.46 n M ; K i(zanamivir) = 0.16 n M)和在10 -8  M的细胞培养中的病毒复制抑制试验中显示出优异的抑制性能。作为该前导优化的一部分,我们现在报告一种新的螺内酰胺,在细胞培养试验中,该螺内酰胺在10 -7  M时的抑制活性与我们的前导化合物相当。在尝试合成原始候选化合物的异硫脲衍生物期间偶然发现了该化合物。螺内酰胺的X射线晶体结构与N8亚型神经氨酸酶复合可提供抑制模式的见解。
  • Carbocycles Related to Oseltamivir as Influenza Virus Group-1-Specific Neuraminidase Inhibitors. Binding to N1 Enzymes in the Context of Virus-like Particles
    作者:Sankar Mohan、Sarah McAtamney、Thomas Haselhorst、Mark von Itzstein、Brian Mario Pinto
    DOI:10.1021/jm100822f
    日期:2010.10.28
    We report here the exploitation of the 150-cavity in the active sites of group-1 neuraminidases for the design of new triazole-containing carbocycles related to oseltamivir. Inhibition studies with virus-like particles (VLPs) containing the influenza virus neuraminidase-1 (NI) activity indicate that several candidates are inhibitors, with K(i) values in the 10(-5)-10(-8) M range. In contrast, a known candidate that preserves the free amino group and a new candidate containing a guanidine function are better inhibitors, with K(i) values of 1.5 x 10(-9) and 4.6 x 10(-10) M, respectively. The most active inhibitor of the N1 enzyme in the triazole series was selective for the N1 class and showed significantly less inhibition (K(i) = 2.6 mu M vs 0.07 mu M) of the free influenza virus neuraminidase-2 (N2). In addition, saturation transfer difference (STD) NMR spectroscopic studies with this compound and the VLPs show that the entire molecule forms contacts with residues in the active site. These data taken together support our proposed binding mode in which the active site and the adjoining 150-cavity are both occupied.
查看更多

同类化合物

艾才派硕 甲基7-氮杂双环[4.1.0]庚-3-烯-7-羧酸酯 甲基2,5-二甲基-1H-氮杂卓-1-羧酸酯 氯化二氢1-[3-(3,5,7-三甲基-2-羰基-2,3--1H-吖庚英-1-基)丙基]哌啶正离子 氮杂环庚烷-2-酮肟 氮杂环丁烷并[1,2-a]噻吩并[2,3-c]吡咯 氮杂环丁烷并[1,2-a][1,3]二氧杂环戊并[4,5-c]吡咯 氮杂环丁烷并[1,2-a][1,2]恶唑并[3,4-d]氮杂卓 氮杂卓-2,7-二酮 替尼拉平 戊四唑 吖庚英并[2,1-a]异喹啉-5(4H)-硫酮,3-甲基- 他利克索 乙基7-氧代-6-氮杂双环[3.2.0]庚-3-烯-6-羧酸酯 [4-(4-甲基苯氧基)苯基]磺酰氯 N-叔丁基-6-甲氧基-5H-吡啶并[2,3-c]氮杂-9-胺 N-丁基-6-甲氧基-5H-吡啶并[2,3-c]氮杂-9-胺 N-Boc-2,3,4,5-四氢氮杂卓 N,N-二乙基-6-硝基-3H-氮杂-2-胺 N,N-二乙基-6-甲氧基-5H-吡啶并[2,3-c]氮杂-9-胺 DL-氨基己内酰胺 C-(6,7,8,9-四氢-5H-[1,2,4]噻唑并[4,3-a]-氮杂革-3-基)-甲基胺 9-氮杂双环[4.2.1]壬-2,4-二烯-9-甲醛 9-氮杂双环[4.2.1]壬-2,4-二烯 9-氮杂双环[4.2.1]壬-2,4,7-三烯-9-甲醛 9-氧杂-6-氮杂三环[4.3.1.03,8]癸-2,4,7-三烯 8-甲基-7H-吡啶并[1,2-a]氮杂-6-酮 7-氧代-6,7-二氢-1H-氮杂卓-4-羧酸 7-氧代-6,7-二氢-1H-氮杂卓-4-磺酰胺 7-乙基-9-甲基-6,7,8,9-四氢-5H-吡嗪并[2,3-d]氮杂卓-2-胺 7-(4-氟苯基)-3,4,5,6-四氢-2H-氮杂卓 6-甲氧基-N-丙基-5H-吡啶并[2,3-c]氮杂-9-胺 6-氮杂双环[3.2.1]辛-3-烯-7-酮 6-氮杂双环[3.2.1]辛-2-烯-7-酮 6-氧杂-4-氮杂三环[5.2.1.04,8]癸-1(9),2,7-三烯 6-BOC-2-溴-5,6,7,8-四氢-4H-噻唑并[4,5-D]吖庚因 6,7-二氮杂三环[5.4.1.01,5]十二碳-2,4,8,10-四烯 6,7-二氢-9-羟基-6-氧代-5H-吡啶并[3,2-b]氮杂卓-8-羧酸乙酯 6,7-二氢-5H-吡啶并[2,3-b]氮杂革-8(9H)-酮 6,7,8,9-四氢-5H-嘧啶并[4,5-d]氮杂卓 6,7,8,9-四氢-5H-咪唑并[1,2-a]氮杂卓-2-甲醛 6,7,8,9-四氢-5H-咪唑[1,2-a]氮杂卓 6,7,8,9-四氢-5H-吡啶并[3,4-c]氮杂卓 6,7,8,9-四氢-5H-吡啶并[3,2-B]氮杂 6,7,8,9-四氢-5H-吡啶并[2,3-d]吖庚因 6,7,8,9-四氢-5H-[1,2,4]噻唑并[4,3-a]氮杂卓-3-硫醇 6,7,8,9-四氢-2-(苯甲基)-5H-嘧啶并[4,5-d]氮杂卓 6,11-二氮杂三环[5.4.0.04,8]十一碳-1(11),4,7,9-四烯 5H-嘧啶并[4,5-d]氮杂卓 5H-嘧啶并[4,5-b]氮杂卓